These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2696739)

  • 41. Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes.
    Montano X; Jimenez A
    Cell Growth Differ; 1995 May; 6(5):597-605. PubMed ID: 7647040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis.
    Peretz D; Kimel N; Fujii DK; Neufeld G
    Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
    Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
    Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mid-G1 arrest and epidermal growth factor independence of ras-transfected mouse cells.
    Leof EB; Lyons RM; Cunningham MR; O'Sullivan D
    Cancer Res; 1989 May; 49(9):2356-61. PubMed ID: 2539900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.
    Ciardiello F; Kim N; Hynes N; Jaggi R; Redmond S; Liscia DS; Sanfilippo B; Merlo G; Callahan R; Kidwell WR
    Mol Endocrinol; 1988 Dec; 2(12):1202-16. PubMed ID: 3063955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contrasting morphological changes in PC12 flat cells expressing two different forms of exogenous oncogenic ras.
    Rozenberg YY; Howard BD
    Exp Cell Res; 1994 Mar; 211(1):59-67. PubMed ID: 8125159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.
    Benjamin CW; Connor JA; Tarpley WG; Gorman RR
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4345-9. PubMed ID: 3288991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
    Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of transformed phenotype induced by a human ras oncogene is inhibited by interferon.
    Samid D; Chang EH; Friedman RM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):509-16. PubMed ID: 3970704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors.
    Pironin M; Clément G; Benzakour O; Barritault D; Lawrence D; Vigier P
    Int J Cancer; 1992 Jul; 51(6):980-8. PubMed ID: 1639543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells.
    Crook T; Storey A; Almond N; Osborn K; Crawford L
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8820-4. PubMed ID: 2848240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of ras oncogenes in chemically transformed BALB/MK-2 mouse keratinocytes.
    Weissman BE; Arboleda MJ; Kimoto KA; MacDonald MJ; Ochiai R; Der CJ
    Mol Carcinog; 1989; 2(3):150-8. PubMed ID: 2506887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumorigenicity of EJ-ras oncogene transformed NIH 3T3 cells and expression of plasminogen activators.
    Sidhu MK; Russo MS; Zirvi KA; Scala L; Kumar S
    Cell Biol Int Rep; 1990 Jun; 14(6):527-42. PubMed ID: 2164452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression.
    McKay IA; Marshall CJ; Calés C; Hall A
    EMBO J; 1986 Oct; 5(10):2617-21. PubMed ID: 3023052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible requirement of serum progression factors for transformation of BALB/c 3T3 fibroblasts by v-ras p21.
    Harada S; Nishimoto I
    FEBS Lett; 1991 Dec; 295(1-3):59-62. PubMed ID: 1765169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocorticoids modulate transformation by v-Src in a cell-specific manner.
    Provenzano C; Alemà S; Falcone G
    Exp Cell Res; 2002 Sep; 279(1):100-10. PubMed ID: 12213218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased p21 levels in anti-sense ras transfectants augments NK sensitivity.
    Anderson SK; Stankova J; Roder JC
    Mol Immunol; 1989 Oct; 26(10):985-91. PubMed ID: 2480518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of ras gene expression on glucocorticoid receptors in mouse fibroblasts.
    Martins VR; Brentani MM
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):183-93. PubMed ID: 1980081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin.
    Gospodarowicz D; Moran JS
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4584-8. PubMed ID: 4531001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.
    Andrejauskas E; Moroni C
    EMBO J; 1989 Sep; 8(9):2575-81. PubMed ID: 2555182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.